Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|14|2|123-125
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.14, Iss.2, 2014-06, pp. : 123-125
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Atrial Fibrillation due to Late Amiodarone-Induced Thyrotoxicosis
Clinical Drug Investigation, Vol. 28, Iss. 8, 2008-01 ,pp. :
The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology
Current Radiopharmaceuticals, Vol. 10, Iss. 3, 2017-11 ,pp. :
Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis
By Uzan Laurent
Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. :